Literature DB >> 16500582

High-sensitivity C-reactive protein and parameters of left ventricular dysfunction.

Sanjiv J Shah1, Gregory M Marcus, Ivor L Gerber, Barry H McKeown, Joshua C Vessey, Mark V Jordan, Michele Huddleston, Elyse Foster, Kanu Chatterjee, Andrew D Michaels.   

Abstract

BACKGROUND: Elevated levels of high-sensitivity C-reactive protein (CRP), an inflammatory marker, have been associated with heart failure. However, it is not known which parameters of left ventricular dysfunction correlate with elevated levels of CRP. METHODS AND
RESULTS: In this cross-sectional study of 98 patients referred for cardiac catheterization, we investigated whether commonly used clinical indices of left ventricular dysfunction correlated with CRP levels. CRP levels were elevated to a greater degree in participants with diabetes mellitus (P =.006) and heart failure (P =.003). Increased CRP levels were associated with increased plasma levels of B-type natriuretic peptide (BNP; P =.0001), decreased left ventricular ejection fraction (LVEF; P =.02), and increased left-ventricular end-diastolic pressure (LVEDP; P =.0005). After multivariable adjustment, LVEDP and CRP were independently associated (P =.046).
CONCLUSION: CRP is increased in patients with heart failure. Of the clinical parameters of left ventricular dysfunction, direct measurement of left ventricular end-diastolic pressure is most closely associated with CRP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500582     DOI: 10.1016/j.cardfail.2005.08.003

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  27 in total

1.  High-sensitivity C-reactive protein (hs-CRP) level in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Walentyna Zoch-Zwierz; Jolanta Tobolczyk; Edyta Tenderenda
Journal:  Pediatr Nephrol       Date:  2006-11-18       Impact factor: 3.714

2.  Interleukin-1 blockade in heart failure with preserved ejection fraction: rationale and design of the Diastolic Heart Failure Anakinra Response Trial 2 (D-HART2).

Authors:  Benjamin W Van Tassell; Leo F Buckley; Salvatore Carbone; Cory R Trankle; Justin M Canada; Dave L Dixon; Nayef Abouzaki; Claudia Oddi-Erdle; Giuseppe Biondi-Zoccai; Ross Arena; Antonio Abbate
Journal:  Clin Cardiol       Date:  2017-05-05       Impact factor: 2.882

3.  Determinants of exercise capacity in dilated cardiomyopathy: a prospective, explorative cohort study.

Authors:  Wilhelm Grander; Bernhard Koller; Johannes Schwaiger; Herbert Tilg; Martin W Dünser
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

4.  Intracardiac and extracardiac markers of inflammation during atrial fibrillation.

Authors:  Gregory M Marcus; Lisa M Smith; Karen Ordovas; Melvin M Scheinman; Albert M Kim; Nitish Badhwar; Randall J Lee; Zian H Tseng; Byron K Lee; Jeffrey E Olgin
Journal:  Heart Rhythm       Date:  2009-10-12       Impact factor: 6.343

Review 5.  Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.

Authors:  Paolo C Colombo; Anjali Ganda; Jeffrey Lin; Duygu Onat; Ante Harxhi; Julia E Iyasere; Nir Uriel; Gad Cotter
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

6.  Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure.

Authors:  Borut Jug; Barbara Guzic Salobir; Nina Vene; Miran Sebestjen; Miso Sabovic; Irena Keber
Journal:  Heart Vessels       Date:  2009-07-22       Impact factor: 2.037

7.  C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study.

Authors:  Eric S Williams; Sanjiv J Shah; Sadia Ali; Bee Ya Na; Nelson B Schiller; Mary A Whooley
Journal:  Eur J Heart Fail       Date:  2007-12-21       Impact factor: 15.534

Review 8.  Targeting interleukin-1 in heart failure and inflammatory heart disease.

Authors:  Benjamin W Van Tassell; Juan M Valle Raleigh; Antonio Abbate
Journal:  Curr Heart Fail Rep       Date:  2015-02

9.  Acute phase proteins and systolic dysfunction in subjects with acute myocardial infarction.

Authors:  Natale Daniele Brunetti; Pier Luigi Pellegrino; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2007-11-24       Impact factor: 2.300

10.  Early Initiation of Sacubitril/Valsartan in Patients with Chronic Heart Failure After Acute Decompensation: A Case Series Analysis.

Authors:  Domenico Acanfora; Pietro Scicchitano; Chiara Acanfora; Roberto Maestri; Fernando Goglia; Raffaele Antonelli Incalzi; Alessandro Santo Bortone; Marco Matteo Ciccone; Massimo Uguccioni; Gerardo Casucci
Journal:  Clin Drug Investig       Date:  2020-05       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.